# An efficient neural network of cooperating serotonergic and noradrenergic neurons in modulating sudden unexpected death in epilepsy

**Authors:** Qing Xu, XiaoXia Xu, LeYuan Gu, YaXuan Wu, Yue Yang, ZhuoYue Zhang, ZiWen Zhang, XuanYi Di, XiTing Lian, Qian Yu, YuLing Wang, HaiXiang Ma, WeiHui Shao, Lu Liu, JiaXuan Gu, Fei Tong, HongHai Zhang

PMC · DOI: 10.7150/ijbs.114659 · 2025-10-10

## TL;DR

This study shows that serotonin and noradrenaline work together in a brain network to reduce sudden death in epilepsy patients.

## Contribution

The study is the first to demonstrate a synergistic effect of serotonergic and noradrenergic systems in reducing SUDEP in mice.

## Key findings

- Elevating serotonin and noradrenaline levels significantly reduced SUDEP incidence in DBA/1 mice.
- Venlafaxine enhances the cooperative regulation of serotonin and noradrenaline in protecting against SUDEP.
- The DR-LC-PBC neural circuit mediates protective effects through 5-HT2A and NE-α1 receptors in the PBC.

## Abstract

Sudden unexpected death in epilepsy (SUDEP) is a critical concern, with seizure-induced respiratory arrest (S-IRA) being a major contributing factor. The serotonergic (5-HT) and noradrenergic (NE) neurons have emerged as key modulators of SUDEP, yet the network-level interactions and specific mechanisms underlying their protective roles remain poorly defined. This study is the first to demonstrate a synergistic effect of 5-HT and NE in mitigating S-IRA and SUDEP using DBA/1 mice. Through a combination of pharmacological interventions, calcium signal recordings, and optogenetics, results show that elevating 5-HT and NE levels via 5-hydroxytryptophan and the norepinephrine reuptake inhibitor atomoxetine significantly reduced SUDEP incidence, with evidence of a robust synergistic interaction. Furthermore, venlafaxine, a selective serotonin-norepinephrine reuptake inhibitor, enhances the cooperative regulation of 5-HT and NE, further supporting their combined protective role. Crucially, the dorsal raphe-locus coeruleus-pre-Bötzinger complex (DR-LC-PBC) neural network is demonstrated as a critical pathway underlying this modulation. Targeted administration of the 5-HT2A/NE α-1 receptor antagonist and agonist into the PBC reveal their pivotal roles in mediating the protective effects of 5-HT and NE. Our study reveals that serotonergic and noradrenergic systems synergistically regulate SUDEP, and further identifies that the DR-LC-PBC neural circuit exerts a protective effect through activation of 5-HT2A and NE-α1 receptors within the PBC.

## Linked entities

- **Chemicals:** 5-hydroxytryptophan (PubChem CID 144), atomoxetine (PubChem CID 54841), venlafaxine (PubChem CID 5656)
- **Diseases:** epilepsy (MONDO:0005027)

## Full-text entities

- **Genes:** Htr2a (5-hydroxytryptamine (serotonin) receptor 2A) [NCBI Gene 15558] {aka 5-HT-2, 5-HT-2A, E030013E04, Htr-2, Htr2}
- **Diseases:** SUDEP (MESH:D000080485), respiratory arrest (MESH:D012131), seizure (MESH:D012640)
- **Chemicals:** 5-HT (MESH:D012701), atomoxetine (MESH:D000069445), S (MESH:D013455), calcium (MESH:D002118), venlafaxine (MESH:D000069470), 5-hydroxytryptophan (MESH:D006916), norepinephrine (MESH:D009638)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** /1 — Mus musculus (Mouse), Hybridoma (CVCL_C7RB)

## Figures

14 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12594605/full.md

---
Source: https://tomesphere.com/paper/PMC12594605